Market capitalization usually refers to the total value of a company's stock within the entire market. The company currently falls under 'Large-Cap' category with total capitalization of 14.8 B. Bio-Rad Laboratories is listed under Measuring and Control category by Fama And French industry classification. Bio-Rad Laboratories was previously known as BIO-RAD LABORATORIES INC and was traded on New York Stock Exchange under the symbol BIO-B. It is located in 1000 Alfred Nobel Drive and employs 7,900 people. Operating Cash Flowīio-Rad Laboratories (BIO) is traded on New York Stock Exchange in USA. When we think about Bio-Rad Laboratories' use of debt, we should always consider it together with cash and equity. Debt, in this case, can be an excellent and much better tool for Bio-Rad to invest in growth at high rates of return. However, a more frequent occurrence is when companies like Bio-Rad Laboratories sell additional shares at bargain prices, diluting existing shareholders. So, Bio-Rad Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. Debt can assist Bio-Rad Laboratories until it has trouble settling it off, either with new capital or with free cash flow. Bio-Rad Laboratories has a current ratio of 4.99, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. The company has 1.4 B in debt with debt to equity (D/E) ratio of 0.14, which may show that the company is not taking advantage of profits from borrowing. It can also help you figure out where your money is going and how much cash you have available at a given moment. Bio-Rad Laboratories cash flow analysis is essential to understand how it generates and spends money over a specific period.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |